Dr. Clemens M. Doppler is Managing Partner at HeidelbergCapital Asset Management GmbH, Chairman at Accovion GmbH, Chairman-Supervisory Board at 4SC AG, a Managing Director at Heidelbergcapital General Partner GmbH and a Member at DVFA e.V.

He is on the Board of Directors at MerLion Pharmaceuticals Pte Ltd., Nanogate AG and vasopharm GmbH. Dr. Doppler was previously employed as Vice Chairman-Supervisory Board by Sensovation AG.

He received his graduate degree from Ruprecht-Karls-Universität Heidelberg.